Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic launched its own drug discovery programs targeting neglected diseases that Big Pharma deems unprofitable. Novartis CEO Vas Narasimhan noted AI could cut development time from twelve to seven or eight years and double success rates from 8 to 16 percent.

Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could cut development time from twelve years to seven or eight and double the success rate from 8 to 16 percent. The article Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable https://the-decoder.com/anthropic-launches-its-own-drug-discovery-programs-to-tackle-diseases-big-pharma-considers-unprofitable/ appeared first on The Decoder https://the-decoder.com .